| Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) RP Warrell Jr, SR Frankel, WH Miller Jr, DA Scheinberg, LM Itri, ... New England Journal of Medicine 324 (20), 1385-1393, 1991 | 1611 | 1991 |
| Human bone marrow–derived mesenchymal stem cells in the treatment of gliomas A Nakamizo, F Marini, T Amano, A Khan, M Studeny, J Gumin, J Chen, ... Cancer research 65 (8), 3307-3318, 2005 | 1405 | 2005 |
| Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia MJ Keating, S O’Brien, M Albitar, S Lerner, W Plunkett, F Giles, M Andreeff, ... Journal of clinical oncology 23 (18), 4079-4088, 2005 | 1333 | 2005 |
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors M Studeny, FC Marini, RE Champlin, C Zompetta, IJ Fidler, M Andreeff Cancer research 62 (13), 3603-3608, 2002 | 1286 | 2002 |
| Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia M Konopleva, R Contractor, T Tsao, I Samudio, PP Ruvolo, S Kitada, ... Cancer cell 10 (5), 375-388, 2006 | 1189 | 2006 |
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents M Studeny, FC Marini, JL Dembinski, C Zompetta, M Cabreira-Hansen, ... Journal of the National Cancer Institute 96 (21), 1593-1603, 2004 | 1113 | 2004 |
| Flow cytometry in clinical cancer research B Barlogie, MN Raber, J Schumann, TS Johnson, B Drewinko, ... Cancer research 43 (9), 3982-3997, 1983 | 1102 | 1983 |
| Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression EL Spaeth, JL Dembinski, AK Sasser, K Watson, A Klopp, B Hall, ... PloS one 4 (4), e4992, 2009 | 997 | 2009 |
| Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias I Tamm, SM Kornblau, H Segall, S Krajewski, K Welsh, S Kitada, ... Clinical Cancer Research 6 (5), 1796-1803, 2000 | 988 | 2000 |
| Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia HM Kantarjian, S O’Brien, TL Smith, J Cortes, FJ Giles, M Beran, S Pierce, ... Journal of Clinical Oncology 18 (3), 547-547, 2000 | 967 | 2000 |
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly … R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ... Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009 | 934 | 2009 |
| MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia R Garzon, S Volinia, CG Liu, C Fernandez-Cymering, T Palumbo, ... Blood, The Journal of the American Society of Hematology 111 (6), 3183-3189, 2008 | 840 | 2008 |
| Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging S Kidd, E Spaeth, JL Dembinski, M Dietrich, K Watson, A Klopp, ... Stem cells 27 (10), 2614-2623, 2009 | 838 | 2009 |
| Cancer stem cell definitions and terminology: the devil is in the details P Valent, D Bonnet, R De Maria, T Lapidot, M Copland, JV Melo, ... Nature Reviews Cancer 12 (11), 767-775, 2012 | 832 | 2012 |
| Convention on nomenclature for DNA cytometry W Hiddemann, J Schumann, M Andreeff, B Barlogie, CJ Herman, RC Leif, ... Cytometry: The Journal of the International Society for Analytical Cytology …, 1984 | 794 | 1984 |
| Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction I Samudio, R Harmancey, M Fiegl, H Kantarjian, M Konopleva, B Korchin, ... The Journal of clinical investigation 120 (1), 142-156, 2010 | 787 | 2010 |
| Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells R Tibes, YH Qiu, Y Lu, B Hennessy, M Andreeff, GB Mills, SM Kornblau Molecular cancer therapeutics 5 (10), 2512-2521, 2006 | 767 | 2006 |
| Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia R Pan, LJ Hogdal, JM Benito, D Bucci, L Han, G Borthakur, J Cortes, ... Cancer discovery 4 (3), 362-375, 2014 | 753 | 2014 |
| Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate DA Thomas, S Faderl, J Cortes, S O'Brien, FJ Giles, SM Kornblau, ... Blood 103 (12), 4396-4407, 2004 | 744 | 2004 |
| Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells E Spaeth, A Klopp, J Dembinski, M Andreeff, F Marini Gene therapy 15 (10), 730-738, 2008 | 743 | 2008 |
